From Reuters: “The dairy producer and rival Fonterra (FCG.NZ)have been advised by U.S.-based trade group International Dairy Foods Association (IDFA) that the FDA has sent similar letters to all firms seeking approvals to sell infant milk formula in the United States.”
From nzherald: "The company has also subsequently been advised by the International Dairy Foods Association that equivalent letters have been sent to all pending enforcement discretion applicants, indicating that the FDA is deferring any further review at this time of all pending applications," a2 Milk said.
Nobody lied and there is no conspiracy here. IDFA advised both Fonterra and a2 about letter sent to all pending applicant. As usual all these debacles because of sh!tty communication. Also FDA did not gave details on why they deferred a2’s application, could be anything, including things not related to a2. Until we know details it’s all speculations, as usual
A2M Price at posting:
$4.76 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)